GDF15 Antikörper (N-Term)
-
- Target Alle GDF15 Antikörper anzeigen
- GDF15 (Growth Differentiation Factor 15 (GDF15))
-
Bindungsspezifität
- AA 30-194, N-Term
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser GDF15 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Cell-ELISA (cELISA)
- Aufreinigung
- Protein G
- Immunogen
- genetic immunisation with cDNA encoding aa30-194 (N-term) of MIC-1 proprotein
- Klon
- ME-6D10
- Isotyp
- IgG1
- Top Product
- Discover our top product GDF15 Primärantikörper
-
-
- Applikationshinweise
-
Flow cytometry: 1.2 µg/10^6 cells
CELISA: 1:200 - 1:400
For each application a titration should be performed to determine the optimal concentration. - Kommentare
-
Synonyms: GDF15
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS, pH 7.2
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- short term: 2 °C - 8 °C, long term: -20 °C
-
- Target
- GDF15 (Growth Differentiation Factor 15 (GDF15))
- Andere Bezeichnung
- MIC-1 (GDF15 Produkte)
- Hintergrund
- Macrophage inhibitory cytokine-1 (MIC-1) is a member of the transforming growth factor-ß superfamily that regulates a wide variety of physiological processes involved in tissue differentiation and maintenance. MIC-1 is synthesized as a 62-kDa intracellular protein, which, after cleavage by a furin like protease, is secreted as a 25-kDa disulphide-linked dimeric protein. Expression of MIC-1 results in inhibition of macrophage activation, regulated by the p53 pathway, in response to pro-inflammatory monokines. MIC-1 is involved in tumour pathogenesis and its measurement can be used as a clinical tool for the diagnosis of a wide range of cancers. It could be a useful marker for aggressive prostate cancer while MIC-1 is upregulated in advanced and more aggressive prostatic tumours.
- UniProt
- Q99988
- Pathways
- SARS-CoV-2 Protein Interaktom
-